1. Home
  2. SPRU vs CGTX Comparison

SPRU vs CGTX Comparison

Compare SPRU & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spruce Power Holding Corporation

SPRU

Spruce Power Holding Corporation

HOLD

Current Price

$4.58

Market Cap

93.0M

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

94.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRU
CGTX
Founded
2008
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.0M
94.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SPRU
CGTX
Price
$4.58
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
111.2K
952.6K
Earning Date
03-30-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$108,010,000.00
N/A
Revenue This Year
$2.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.22
N/A
52 Week Low
$1.13
$0.22
52 Week High
$6.75
$3.83

Technical Indicators

Market Signals
Indicator
SPRU
CGTX
Relative Strength Index (RSI) 31.51 39.88
Support Level $4.96 $1.05
Resistance Level $6.75 $1.21
Average True Range (ATR) 0.49 0.10
MACD -0.21 0.00
Stochastic Oscillator 0.00 28.57

Price Performance

Historical Comparison
SPRU
CGTX

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: